Mepolizumab for Eosinophilic COPD
N Engl J Med
.
2018 Feb 15;378(7):681.
doi: 10.1056/NEJMc1715454.
Authors
Parichehr Shahlavi‑Monavvar
1
,
Abdolkarim Mobasher-Jannat
2
Affiliations
1
Tabriz University of Medical Sciences, Tabriz, Iran
2
Baqiyatallah University of Medical Sciences, Tehran, Iran karim.jannat@yahoo.com
PMID:
29446292
DOI:
10.1056/NEJMc1715454
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Asthmatic Agents*
Antibodies, Monoclonal, Humanized*
Asthma
Eosinophils
Humans
Pulmonary Disease, Chronic Obstructive
Substances
Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
mepolizumab